Search

everythinglearnresearchcommunity

for

Search:↓

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

Brandt syndrome, with symptoms like skin rash, hair loss, and diarrhea, improves quickly with zinc supplements.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Finasteride, a hair loss drug, caused a skin rash that went away when the drug was stopped and returned when used again.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Scurvy still occurs today and can be diagnosed by symptoms like gum bleeding and a specific rash, confirmed by low vitamin C levels.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Tph cells are linked to the severity of systemic lupus erythematosus.

A risk prediction model can help diagnose systemic lupus erythematosus earlier in primary care.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The drug combination was safe and showed promise in treating advanced tumors.